Observational and genetic studies of C-reactive protein levels and risk of Alzheimer's disease

Research output: Contribution to journalComment/debateResearchpeer-review

Original languageEnglish
JournalAlzheimer's and Dementia
Volume18
Issue number12
Pages (from-to) 2734-2735
ISSN1552-5260
DOIs
Publication statusPublished - 2022

Bibliographical note

Funding Information:
Sharif H. Hegazy, Jesper Qvist Thomassen, Ida Juul Rasmussen, and Anne Tybjærg‐Hansen have nothing to disclose. Børge G. Nordestgaard received consulting fees (personal fees) from AstraZeneca, Sanofi, Regeneron, Akcea, Amgen, Kowa, Denka, Amarin, Novartis, Novo Nordisk, Esperion, and Silence Therapeutics. RFS received consulting fees (personal fees) from Novo Nordisk. The Lundbeck Foundation, the Danish Heart Foundation, and the Independent Research Fund Denmark. Author disclosures are available in the supporting information.

ID: 325825608